Skip to main content

Table 4 Antibacterial and antifungal activity of compounds 2, 3, and 4 (diameter of inhibition zone is given in mm)

From: Synthesis, characterization, X-ray structure, computational studies, and bioassay of novel compounds combining thiophene and benzimidazole or 1,2,4-triazole moieties

A) Antifungal activity

Tested pathogen

FUNGI

A. fumigates

S. racemosum

G. candidum

Candida albicans

 

Amphotericin B

Reference compound

23.7 ± 0.1

19.7 ± 0.2

28.7 ± 0.2

25.4 ± 0.1

2

16.2 ± 0.4

15.0 ± 0.4

17.6 ± 0.6

NA

3

21.3 ± 0.4

17.2 ± 0.2

24.6 ± 0.6

NA

4

17.6 ± 0.6

15.4 ± 0.3

12.6 ± 0.4

NA

B) Antibacterial activity

Tested pathogen

Gram positive bacteria

Gram negative bacteria

S. pneumoniae

B. subtilis

P. aeruginosa

E. coli

 

Ampicillin

Gentamicin

Reference compounds

23.8 ± 0.2

32.4 ± 0.3

17.3 ± 0.1

19.9 ± 0.3

2

16.9 ± 0.6

18.2 ± 0.4

NA

11.9 ± 0.6

3

18.2 ± 0.1

20.3 ± 0.1

NA

20.3 ± 0.1

4

12.3 ± 0.6

12.7 ± 0.4

NA

8.5 ± 0.4